Marrero JA - Search Results

1

Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma.

Marrero JA, Feng Z, Wang Y, Nguyen MH, Befeler AS, Roberts LR, Reddy KR, Harnois D, Llovet JM, Normolle D, Dalhgren J, Chia D, Lok AS, Wagner PD, Srivastava S, Schwartz M. Marrero JA, et al. Gastroenterology. 2009 Jul;137(1):110-8. doi: 10.1053/j.gastro.2009.04.005. Epub 2009 Apr 9. Gastroenterology. 2009. PMID: 19362088 Free PMC article.

2

NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States.

Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS. Marrero JA, et al. Hepatology. 2002 Dec;36(6):1349-54. doi: 10.1053/jhep.2002.36939. Hepatology. 2002. PMID: 12447858 Free article.

3

Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation.

Fontana RJ, Hamidullah H, Nghiem H, Greenson JK, Hussain H, Marrero J, Rudich S, McClure LA, Arenas J. Fontana RJ, et al. Liver Transpl. 2002 Dec;8(12):1165-74. doi: 10.1053/jlts.2002.36394. Liver Transpl. 2002. PMID: 12474157 Free article.

4

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients.

Marrero JA, Su GL, Wei W, Emick D, Conjeevaram HS, Fontana RJ, Lok AS. Marrero JA, et al. Hepatology. 2003 May;37(5):1114-21. doi: 10.1053/jhep.2003.50195. Hepatology. 2003. PMID: 12717392

5

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS. Wai CT, et al. Among authors: marrero ja. Hepatology. 2003 Aug;38(2):518-26. doi: 10.1053/jhep.2003.50346. Hepatology. 2003. PMID: 12883497 Free article.

6

Occult hepatitis B virus infection in patients with hepatocellular carcinoma: Innocent bystander, cofactor, or culprit?

Marrero JA, Lok AS. Marrero JA, et al. Gastroenterology. 2004 Jan;126(1):347-50. doi: 10.1053/j.gastro.2003.11.021. Gastroenterology. 2004. PMID: 14699513 Review. No abstract available.

7

Effectiveness of interferon alpha-2b and ribavirin combination therapy in the treatment of naive chronic hepatitis C patients in clinical practice.

Shehab TM, Fontana RJ, Oberhelman K, Marrero JA, Su GL, Lok AS. Shehab TM, et al. Among authors: marrero ja. Clin Gastroenterol Hepatol. 2004 May;2(5):425-31. doi: 10.1016/s1542-3565(04)00018-7. Clin Gastroenterol Hepatol. 2004. PMID: 15118982

8

Newer markers for hepatocellular carcinoma.

Marrero JA, Lok AS. Marrero JA, et al. Gastroenterology. 2004 Nov;127(5 Suppl 1):S113-9. doi: 10.1053/j.gastro.2004.09.024. Gastroenterology. 2004. PMID: 15508074 Review.

9

Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma.

Marrero JA, Fontana RJ, Fu S, Conjeevaram HS, Su GL, Lok AS. Marrero JA, et al. J Hepatol. 2005 Feb;42(2):218-24. doi: 10.1016/j.jhep.2004.10.005. J Hepatol. 2005. PMID: 15664247

10

Hepatocellular carcinoma.

Marrero JA. Marrero JA. Curr Opin Gastroenterol. 2003 May;19(3):243-9. doi: 10.1097/00001574-200305000-00007. Curr Opin Gastroenterol. 2003. PMID: 15703564

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters